Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Hui Guo, Ding"'
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 21, Pp 2544-2546 (2021)
Externí odkaz:
https://doaj.org/article/81fec15596614d1c9a52d974c5ab8564
Publikováno v:
Journal of Clinical & Translational Hepatology; Jul2024, Vol. 12 Issue 7, p625-633, 9p
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 19, Pp 2362-2364 (2020)
Externí odkaz:
https://doaj.org/article/d4d122d6fb7844f4b1566eccc6877f0e
Autor:
Shuzhen Wang, Xin Zhang, Tao Han, Wen Xie, Yonggang Li, Hong Ma, Roman Liebe, Honglei Weng, Hui-Guo Ding
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Although tolvaptan treatment improves hyponatremia, only few studies have investigated whether tolvaptan actually benefits the survival of cirrhotic patients. This study evaluated the impact of tolvaptan on six-month survival of d
Externí odkaz:
https://doaj.org/article/e01ceba01ec7496399e072f9e2ad681a
Autor:
Ji-Dong Jia, Wen Xie, Hui-Guo Ding, Hua Mao, Hui Guo, Yonggang Li, Xiaojin Wang, Jie-Fei Wang, Wei Lu, Cheng-Zhong Li, Yimin Mao, Gui-Qiang Wang, Yue-qiu Gao, Bangmao Wang, Qin Zhang, Yan Ge, Vincent Wai-Sun Wong
Publikováno v:
Annals of Hepatology, Vol 16, Iss 1, Pp 123-132 (2017)
Introduction and aim: Hyponatremia is common in patients with decompensated cirrhosis and is associated with increased mortality. Tolvaptan, a vasopressor V2 receptor antagonist, can increase free water excretion, but its efficacy and safety in cirrh
Externí odkaz:
https://doaj.org/article/f319569c90ea4f349fc3fcc8b7dcebad
Publikováno v:
World Chinese Journal of Digestology. 30:729-734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a873ce2b81e4a4d5b735d08f2fd048d8
https://doi.org/10.11569/wcjd.v30.i16.729
https://doi.org/10.11569/wcjd.v30.i16.729
Autor:
Xuan-Hui, Yan, Zhen-Dong, Yue, Hong-Wei, Zhao, Lei, Wang, Zhen-Hua, Fan, Yi-Fan, Wu, Ming-Ming, Meng, Ke, Zhang, Li, Jiang, Hui-Guo, Ding, Yue-Ning, Zhang, Yong-Ping, Yang, Fu-Quan, Liu
Publikováno v:
World Journal of Gastrointestinal Surgery. 14:567-579
Patients with hepatocellular carcinoma complicated with main portal vein tumor thrombosis (mPVTT) and cirrhotic portal hypertension (CPH) have an extremely poor prognosis, and there is a lack of a clinically effective treatment paradigm.To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00dc67143cd88e5acf98ce3dfec6d6e5
https://doi.org/10.4240/wjgs.v14.i6.567
https://doi.org/10.4240/wjgs.v14.i6.567
Autor:
Zi-Jin Liu, Hui-Guo Ding
Publikováno v:
World Chinese Journal of Digestology. 29:966-971
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ea7fa672f0d2c701dad4aa01718575
https://doi.org/10.11569/wcjd.v29.i16.966
https://doi.org/10.11569/wcjd.v29.i16.966
Autor:
Hui-Guo Ding, Lin Wei
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Peptic ulcer (PU) is more prevalent in patients with liver cirrhosis. The role of Helicobacter pylori (H. pylori) infection in the pathogenesis of PU in patients with cirrhosis is still not elucidated. AIM To perform a meta-analysis on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4de2af28943cc5b200eff915cd3bd7b
http://europepmc.org/articles/PMC8409208
http://europepmc.org/articles/PMC8409208
Publikováno v:
World Journal of Clinical Cases
BACKGROUND The impact of type 2 diabetes mellitus (T2DM) on the prognosis and complications of liver cirrhosis is not fully clarified. AIM To clarify the mortality and related risk factors as well as complications in cirrhotic patients with T2DM. MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1e0ef6abc2db6464ddacd66f79b2f4
https://doi.org/10.12998/wjcc.v9.i20.5514
https://doi.org/10.12998/wjcc.v9.i20.5514